Concepts (275)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pregnancy | 49 | 2026 | 1555 | 2.990 |
Why?
|
| Pregnancy Complications | 12 | 2025 | 202 | 2.350 |
Why?
|
| Gynecology | 3 | 2024 | 21 | 2.030 |
Why?
|
| Obesity | 15 | 2025 | 811 | 2.000 |
Why?
|
| Weight Loss | 5 | 2026 | 302 | 1.980 |
Why?
|
| Weight Gain | 13 | 2026 | 167 | 1.860 |
Why?
|
| Pediatric Obesity | 3 | 2026 | 101 | 1.750 |
Why?
|
| Female | 64 | 2026 | 12193 | 1.560 |
Why?
|
| Weight Reduction Programs | 3 | 2026 | 51 | 1.460 |
Why?
|
| Adult | 44 | 2026 | 7255 | 1.410 |
Why?
|
| Humans | 66 | 2026 | 16832 | 1.390 |
Why?
|
| Prenatal Care | 5 | 2020 | 123 | 1.300 |
Why?
|
| Diabetes, Gestational | 10 | 2021 | 330 | 1.300 |
Why?
|
| Pregnancy Outcome | 11 | 2024 | 160 | 1.290 |
Why?
|
| Menopause | 6 | 2024 | 60 | 1.240 |
Why?
|
| Postpartum Period | 6 | 2026 | 89 | 1.180 |
Why?
|
| Preconception Care | 3 | 2026 | 43 | 1.140 |
Why?
|
| Mass Screening | 9 | 2021 | 670 | 1.010 |
Why?
|
| Young Adult | 19 | 2026 | 2456 | 0.980 |
Why?
|
| Infant, Newborn | 14 | 2026 | 828 | 0.940 |
Why?
|
| Adiposity | 1 | 2026 | 69 | 0.910 |
Why?
|
| Insulin Resistance | 1 | 2026 | 127 | 0.910 |
Why?
|
| Vaccination | 9 | 2026 | 725 | 0.890 |
Why?
|
| Body Mass Index | 14 | 2026 | 925 | 0.870 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2023 | 40 | 0.870 |
Why?
|
| Infant, Small for Gestational Age | 5 | 2024 | 55 | 0.850 |
Why?
|
| Obstetrics | 1 | 2024 | 20 | 0.810 |
Why?
|
| Health Services | 3 | 2020 | 100 | 0.800 |
Why?
|
| Blood Pressure Determination | 1 | 2023 | 57 | 0.780 |
Why?
|
| Internship and Residency | 1 | 2024 | 58 | 0.780 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 87 | 0.700 |
Why?
|
| Retrospective Studies | 13 | 2026 | 2463 | 0.660 |
Why?
|
| Glucose Tolerance Test | 8 | 2021 | 108 | 0.650 |
Why?
|
| Urogenital System | 1 | 2020 | 2 | 0.640 |
Why?
|
| Vulvovaginitis | 1 | 2020 | 3 | 0.640 |
Why?
|
| Urologic Diseases | 1 | 2020 | 5 | 0.640 |
Why?
|
| Insurance Claim Review | 1 | 2020 | 48 | 0.610 |
Why?
|
| Fractures, Bone | 4 | 2012 | 92 | 0.610 |
Why?
|
| Premature Birth | 5 | 2024 | 133 | 0.600 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 290 | 0.590 |
Why?
|
| Medicaid | 2 | 2020 | 189 | 0.580 |
Why?
|
| Fetal Macrosomia | 5 | 2021 | 27 | 0.570 |
Why?
|
| Blood Glucose | 2 | 2021 | 315 | 0.550 |
Why?
|
| Managed Care Programs | 1 | 2020 | 275 | 0.550 |
Why?
|
| Health Care Costs | 1 | 2020 | 192 | 0.540 |
Why?
|
| Counseling | 2 | 2016 | 170 | 0.530 |
Why?
|
| Primary Health Care | 2 | 2020 | 693 | 0.530 |
Why?
|
| Life Style | 3 | 2026 | 305 | 0.510 |
Why?
|
| Infant | 9 | 2026 | 1212 | 0.500 |
Why?
|
| Postnatal Care | 1 | 2016 | 20 | 0.490 |
Why?
|
| United States | 13 | 2026 | 3858 | 0.490 |
Why?
|
| Cohort Studies | 13 | 2023 | 2396 | 0.480 |
Why?
|
| Ovariectomy | 3 | 2012 | 7 | 0.460 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 353 | 0.450 |
Why?
|
| Cervical Intraepithelial Neoplasia | 2 | 2011 | 16 | 0.430 |
Why?
|
| Intra-Abdominal Fat | 2 | 2026 | 17 | 0.430 |
Why?
|
| Vaginal Smears | 2 | 2011 | 47 | 0.430 |
Why?
|
| Group Processes | 1 | 2014 | 8 | 0.430 |
Why?
|
| Hospitalization | 1 | 2020 | 816 | 0.420 |
Why?
|
| Liver | 2 | 2026 | 31 | 0.420 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2011 | 130 | 0.380 |
Why?
|
| Insulin | 1 | 2013 | 181 | 0.370 |
Why?
|
| Adolescent | 11 | 2026 | 3464 | 0.370 |
Why?
|
| Gestational Age | 7 | 2025 | 118 | 0.370 |
Why?
|
| Exercise Therapy | 2 | 2015 | 71 | 0.370 |
Why?
|
| Menopause, Premature | 1 | 2012 | 3 | 0.360 |
Why?
|
| Carpal Bones | 1 | 2012 | 3 | 0.360 |
Why?
|
| Diet Therapy | 1 | 2012 | 9 | 0.360 |
Why?
|
| Psychotherapy, Group | 1 | 2012 | 20 | 0.360 |
Why?
|
| Guideline Adherence | 1 | 2013 | 155 | 0.350 |
Why?
|
| Papanicolaou Test | 1 | 2011 | 36 | 0.350 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 247 | 0.330 |
Why?
|
| Electronic Health Records | 3 | 2025 | 702 | 0.330 |
Why?
|
| Treatment Outcome | 5 | 2020 | 1098 | 0.310 |
Why?
|
| Lactation | 2 | 2026 | 37 | 0.290 |
Why?
|
| Affect | 1 | 2007 | 21 | 0.270 |
Why?
|
| Women's Health | 1 | 2007 | 178 | 0.250 |
Why?
|
| Middle Aged | 10 | 2024 | 7515 | 0.250 |
Why?
|
| Pregnancy Trimester, First | 2 | 2024 | 45 | 0.240 |
Why?
|
| Milk, Human | 1 | 2026 | 9 | 0.240 |
Why?
|
| Glucose Clamp Technique | 1 | 2026 | 17 | 0.240 |
Why?
|
| Logistic Models | 4 | 2013 | 796 | 0.240 |
Why?
|
| Mental Health | 1 | 2007 | 161 | 0.240 |
Why?
|
| Follow-Up Studies | 4 | 2026 | 1058 | 0.240 |
Why?
|
| Muscle, Skeletal | 1 | 2026 | 38 | 0.240 |
Why?
|
| Body Composition | 1 | 2026 | 90 | 0.240 |
Why?
|
| Language | 1 | 2026 | 51 | 0.230 |
Why?
|
| Body Weight | 3 | 2016 | 197 | 0.230 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 677 | 0.230 |
Why?
|
| Mothers | 2 | 2016 | 104 | 0.230 |
Why?
|
| Thinness | 4 | 2025 | 31 | 0.230 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2024 | 158 | 0.220 |
Why?
|
| Risk Factors | 9 | 2021 | 3108 | 0.220 |
Why?
|
| Washington | 4 | 2020 | 376 | 0.220 |
Why?
|
| Breast Feeding | 1 | 2026 | 112 | 0.220 |
Why?
|
| Mastitis | 1 | 2024 | 2 | 0.220 |
Why?
|
| Community Health Centers | 1 | 2025 | 58 | 0.220 |
Why?
|
| Osteoporosis | 2 | 2011 | 73 | 0.220 |
Why?
|
| Child, Preschool | 3 | 2026 | 1430 | 0.220 |
Why?
|
| International Classification of Diseases | 1 | 2024 | 84 | 0.210 |
Why?
|
| Stillbirth | 1 | 2024 | 29 | 0.210 |
Why?
|
| Quality of Life | 2 | 2023 | 477 | 0.210 |
Why?
|
| Oregon | 3 | 2020 | 168 | 0.200 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 445 | 0.200 |
Why?
|
| Infant, Premature | 2 | 2022 | 59 | 0.200 |
Why?
|
| Diet | 2 | 2016 | 349 | 0.200 |
Why?
|
| Curriculum | 1 | 2024 | 51 | 0.200 |
Why?
|
| Longitudinal Studies | 1 | 2026 | 653 | 0.200 |
Why?
|
| Healthcare Disparities | 1 | 2026 | 213 | 0.200 |
Why?
|
| Organ Size | 2 | 2021 | 16 | 0.200 |
Why?
|
| Child | 3 | 2026 | 2433 | 0.200 |
Why?
|
| Precision Medicine | 1 | 2023 | 28 | 0.190 |
Why?
|
| Clinical Competence | 1 | 2024 | 107 | 0.190 |
Why?
|
| Prospective Studies | 3 | 2023 | 1186 | 0.190 |
Why?
|
| Adipose Tissue | 1 | 2023 | 63 | 0.190 |
Why?
|
| Lipids | 1 | 2023 | 66 | 0.190 |
Why?
|
| Abortion, Spontaneous | 1 | 2023 | 49 | 0.190 |
Why?
|
| Advisory Committees | 1 | 2023 | 112 | 0.180 |
Why?
|
| Granulosa Cell Tumor | 1 | 2002 | 1 | 0.180 |
Why?
|
| Male | 8 | 2026 | 9556 | 0.180 |
Why?
|
| Odds Ratio | 4 | 2011 | 569 | 0.170 |
Why?
|
| Ovarian Neoplasms | 1 | 2002 | 53 | 0.170 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2022 | 104 | 0.170 |
Why?
|
| Papillomaviridae | 2 | 2011 | 58 | 0.170 |
Why?
|
| Pregnancy Trimester, Third | 4 | 2026 | 22 | 0.170 |
Why?
|
| Hip Fractures | 2 | 2012 | 72 | 0.170 |
Why?
|
| Aspirin | 1 | 2021 | 61 | 0.170 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 57 | 0.170 |
Why?
|
| Pre-Eclampsia | 1 | 2021 | 41 | 0.170 |
Why?
|
| Cost of Illness | 2 | 2020 | 90 | 0.160 |
Why?
|
| Pregnant Women | 1 | 2021 | 41 | 0.160 |
Why?
|
| Exercise | 1 | 2025 | 513 | 0.160 |
Why?
|
| Incidence | 3 | 2021 | 1229 | 0.160 |
Why?
|
| Syndrome | 1 | 2020 | 22 | 0.160 |
Why?
|
| Vaccination Coverage | 1 | 2021 | 68 | 0.160 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2002 | 222 | 0.160 |
Why?
|
| Papillomavirus Infections | 2 | 2011 | 141 | 0.150 |
Why?
|
| Morbidity | 1 | 2020 | 56 | 0.150 |
Why?
|
| Atrophy | 1 | 2019 | 5 | 0.150 |
Why?
|
| Prognosis | 2 | 2019 | 568 | 0.150 |
Why?
|
| Attitude | 1 | 2019 | 27 | 0.150 |
Why?
|
| Anxiety | 2 | 2013 | 154 | 0.150 |
Why?
|
| Prenatal Diagnosis | 1 | 2019 | 20 | 0.150 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 45 | 0.140 |
Why?
|
| Sensitivity and Specificity | 4 | 2014 | 291 | 0.140 |
Why?
|
| Nocturnal Myoclonus Syndrome | 1 | 2008 | 1 | 0.140 |
Why?
|
| Polysomnography | 1 | 2008 | 5 | 0.140 |
Why?
|
| Wrist | 1 | 2008 | 2 | 0.140 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2008 | 8 | 0.140 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 122 | 0.140 |
Why?
|
| Sleep Wake Disorders | 1 | 2008 | 31 | 0.140 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 134 | 0.140 |
Why?
|
| Clinical Protocols | 2 | 2019 | 38 | 0.130 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2016 | 12 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 311 | 0.120 |
Why?
|
| Overweight | 4 | 2024 | 262 | 0.120 |
Why?
|
| Bronchodilator Agents | 1 | 2016 | 21 | 0.120 |
Why?
|
| Aged | 6 | 2012 | 5901 | 0.110 |
Why?
|
| Research Design | 2 | 2019 | 319 | 0.110 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 657 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2022 | 1047 | 0.110 |
Why?
|
| Cesarean Section, Repeat | 1 | 2014 | 2 | 0.110 |
Why?
|
| Confidence Intervals | 2 | 2014 | 207 | 0.110 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2014 | 3 | 0.110 |
Why?
|
| Pamphlets | 1 | 2014 | 7 | 0.110 |
Why?
|
| Self-Help Groups | 1 | 2014 | 22 | 0.110 |
Why?
|
| Energy Intake | 1 | 2014 | 98 | 0.100 |
Why?
|
| Aging | 2 | 2005 | 146 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2015 | 142 | 0.100 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2012 | 91 | 0.100 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 206 | 0.100 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1993 | 1 | 0.100 |
Why?
|
| Infant Care | 1 | 2013 | 7 | 0.100 |
Why?
|
| Pregnancy Trimesters | 2 | 2025 | 27 | 0.090 |
Why?
|
| Asthma | 1 | 2016 | 375 | 0.090 |
Why?
|
| Depression, Postpartum | 1 | 2013 | 27 | 0.090 |
Why?
|
| Child Health Services | 1 | 2013 | 104 | 0.090 |
Why?
|
| Term Birth | 1 | 2012 | 9 | 0.090 |
Why?
|
| Intention to Treat Analysis | 1 | 2012 | 19 | 0.090 |
Why?
|
| Comorbidity | 2 | 2008 | 516 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 96 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 129 | 0.090 |
Why?
|
| Spinal Fractures | 1 | 2012 | 12 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 103 | 0.090 |
Why?
|
| Remission, Spontaneous | 1 | 2011 | 5 | 0.090 |
Why?
|
| Body Height | 1 | 2012 | 54 | 0.090 |
Why?
|
| Health Maintenance Organizations | 1 | 2013 | 358 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2012 | 108 | 0.090 |
Why?
|
| World Health Organization | 1 | 2011 | 10 | 0.090 |
Why?
|
| Models, Biological | 1 | 2011 | 26 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 317 | 0.090 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 39 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2011 | 294 | 0.080 |
Why?
|
| Delivery of Health Care | 1 | 2013 | 374 | 0.070 |
Why?
|
| Depression | 2 | 2008 | 479 | 0.070 |
Why?
|
| Age Factors | 1 | 2011 | 814 | 0.070 |
Why?
|
| Early Detection of Cancer | 2 | 2011 | 553 | 0.070 |
Why?
|
| Hot Flashes | 2 | 2006 | 37 | 0.070 |
Why?
|
| Premenopause | 1 | 2007 | 20 | 0.070 |
Why?
|
| Perimenopause | 1 | 2007 | 9 | 0.070 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 34 | 0.070 |
Why?
|
| Causality | 1 | 2007 | 32 | 0.070 |
Why?
|
| Psychometrics | 1 | 2007 | 114 | 0.060 |
Why?
|
| Time Factors | 3 | 2020 | 989 | 0.060 |
Why?
|
| Respiratory Tract Infections | 1 | 2026 | 58 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2008 | 1887 | 0.060 |
Why?
|
| Live Birth | 1 | 2024 | 7 | 0.050 |
Why?
|
| Congenital Abnormalities | 1 | 2024 | 26 | 0.050 |
Why?
|
| Safety-net Providers | 1 | 2025 | 52 | 0.050 |
Why?
|
| Self Report | 1 | 2025 | 248 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 35 | 0.050 |
Why?
|
| Consensus | 1 | 2023 | 40 | 0.050 |
Why?
|
| Maternal Age | 1 | 2023 | 73 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2023 | 66 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 145 | 0.050 |
Why?
|
| Delivery, Obstetric | 2 | 2013 | 16 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2023 | 160 | 0.050 |
Why?
|
| Hysterectomy | 1 | 2002 | 19 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2021 | 2 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2021 | 3 | 0.040 |
Why?
|
| Weaning | 1 | 2021 | 3 | 0.040 |
Why?
|
| Parturition | 1 | 2021 | 7 | 0.040 |
Why?
|
| Length of Stay | 2 | 2013 | 169 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2021 | 16 | 0.040 |
Why?
|
| Perinatal Death | 1 | 2021 | 2 | 0.040 |
Why?
|
| Glucose | 1 | 2021 | 29 | 0.040 |
Why?
|
| Postpartum Hemorrhage | 1 | 2021 | 4 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2024 | 995 | 0.040 |
Why?
|
| Patient Safety | 1 | 2022 | 37 | 0.040 |
Why?
|
| Socioeconomic Factors | 2 | 2013 | 571 | 0.040 |
Why?
|
| Prevalence | 1 | 2022 | 785 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 1233 | 0.040 |
Why?
|
| Bone Density | 2 | 2011 | 93 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2016 | 29 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2021 | 515 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2015 | 22 | 0.030 |
Why?
|
| Trial of Labor | 1 | 2014 | 1 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2016 | 400 | 0.030 |
Why?
|
| Patient Preference | 1 | 2014 | 46 | 0.030 |
Why?
|
| Acoustic Stimulation | 1 | 1993 | 1 | 0.020 |
Why?
|
| Auditory Threshold | 1 | 1993 | 1 | 0.020 |
Why?
|
| Reaction Time | 1 | 1993 | 3 | 0.020 |
Why?
|
| Electroencephalography | 1 | 1993 | 4 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 1993 | 9 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1993 | 120 | 0.020 |
Why?
|
| Health Behavior | 1 | 2015 | 332 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 261 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2012 | 34 | 0.020 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2012 | 34 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2011 | 10 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2012 | 161 | 0.020 |
Why?
|
| Perinatal Mortality | 1 | 2008 | 3 | 0.020 |
Why?
|
| Maternal Mortality | 1 | 2008 | 3 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 393 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2008 | 73 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2006 | 2 | 0.020 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2006 | 2 | 0.020 |
Why?
|
| Trifolium | 1 | 2006 | 2 | 0.020 |
Why?
|
| Soybeans | 1 | 2006 | 4 | 0.020 |
Why?
|
| Clonidine | 1 | 2006 | 3 | 0.020 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2006 | 3 | 0.020 |
Why?
|
| Amines | 1 | 2006 | 4 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2006 | 4 | 0.020 |
Why?
|
| Isoflavones | 1 | 2006 | 14 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2006 | 14 | 0.010 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2006 | 45 | 0.010 |
Why?
|
| Ovary | 1 | 2005 | 5 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 140 | 0.010 |
Why?
|
| Testosterone | 1 | 2004 | 19 | 0.010 |
Why?
|
| Estradiol | 1 | 2004 | 20 | 0.010 |
Why?
|
| Research | 1 | 2005 | 53 | 0.010 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2004 | 42 | 0.010 |
Why?
|
| Postmenopause | 1 | 2004 | 243 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 453 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 489 | 0.010 |
Why?
|
Concepts
(275)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->